News

How AI and Robotics Are Transforming IVF

IVF involves several delicate steps, with sperm and embryo selection being among the most crucial. Traditionally, these processes rely on embryologists manually analyzing sperm and embryos under a microscope. This method, while effective, is subjective and prone to human error.

IISc’s solution integrates AI-powered computer-aided semen analysis (CASA) and quantitative embryo assessment techniques to automate and enhance accuracy. Machine learning algorithms assess sperm motility, morphology, and viability, while AI-driven embryo selection identifies the healthiest embryos with the highest chances of implantation. This innovation minimizes human bias and increases the efficiency of fertility treatments.

The Role of CASA in Fertility Success

Computer-aided semen analysis (CASA) is a sophisticated imaging and analysis tool that evaluates sperm quality with precision. IISc’s AI-enhanced CASA system provides:

• Sperm Movement Analysis – AI tracks motility patterns, identifying the most active and viable sperm.
• Morphology Assessment – Advanced imaging detects structural abnormalities in sperm, ensuring only the best are selected.
• Viability Testing – AI determines sperm health, improving fertilization chances.

These automated assessments help embryologists make data-driven decisions, reducing the risk of selecting suboptimal sperm for fertilization.

AI in Embryo Selection: A Game-Changer

Beyond sperm analysis, IISc is also working on AI-based embryo selection. Currently, embryologists visually grade embryos based on appearance, which can be inconsistent. IISc’s AI-driven embryo assessment uses deep learning to analyze embryo development patterns, predicting which embryos are most likely to result in a successful pregnancy.

By eliminating subjective evaluations, this technology enhances precision and increases the likelihood of successful implantation. As a result, it reduces the number of IVF cycles required, saving time, emotional distress, and financial costs for patients.

AI-Enhanced Cryopreservation: A New Frontier in IVF

Beyond sperm and embryo selection, IISc is also exploring AI-powered cryopreservation techniques to improve the storage and longevity of reproductive cells. Cryopreservation, or freezing sperm and embryos for future use, is a critical component of IVF. However, the freezing and thawing process can sometimes damage cells, reducing their viability.

By integrating AI-driven monitoring systems, IISc aims to optimize freezing rates, detect minute changes in cell integrity, and enhance post-thaw survival rates. This breakthrough could revolutionize fertility preservation, offering couples greater flexibility in planning their pregnancies while ensuring higher success rates with stored reproductive material.

The Future of AI-Driven IVF Treatments

IISc’s advancements in AI and robotics for IVF represent a significant leap in reproductive medicine. As these technologies continue to evolve, they could make IVF more efficient, accessible, and successful. Clinics worldwide may soon adopt similar AI-driven models, reshaping fertility treatments and offering new possibilities to those hoping to conceive.

With AI taking center stage in medical innovation, IISc’s research could be a turning point in the global IVF landscape, bringing science and technology together to create families.

Reference : https://www.magzter.com/stories/newspaper/The-New-Indian-Express-Bengaluru/IISCS-AI-ROBOTICS-SET-TO-REVOLUTIONISE-IVF-SUCCESS?srsltid=AfmBOop2r8xkORj7As3sSnk9CPp8tPcRlgsliwAtl92XnuNIHwSIkOnK 

disrupts hormones, damages the uterus and ovaries, and increases infertility risks. 

The Study Exposes Alarming Risks of the World’s Most Widely Used Herbicide

The study suggests that glyphosate may contribute to polycystic ovary syndrome (PCOS) and endometriosis, two leading causes of infertility in women. With glyphosate use increasing globally, experts are now urging immediate action to regulate and reduce exposure to safeguard female reproductive health.

A Chemical Lurking in Everyday Life

Glyphosate, the active ingredient in Roundup® and similar weed killers, is sprayed on crops, lawns, and public spaces. In the U.S. alone, over 240 million pounds of glyphosate are applied annually, making it nearly impossible to avoid.

People are exposed through:

• Food & Water – Residues found in fruits, vegetables, grains, and even drinking water.
• Air & Soil – Spraying disperses glyphosate into the environment.
• Skin Contact – Direct exposure from gardening or handling contaminated surfaces.

A 2022 study detected glyphosate in more than 80% of urine samples from U.S. adults and children, highlighting its widespread presence in human bodies.

How Glyphosate Wreaks Havoc on Female Reproductive Health

The study reviewed decades of research and identified several ways glyphosate harms fertility and increases reproductive health risks:

1. Pregnancy Complications

Glyphosate interferes with essential pregnancy hormones like estrogen and progesterone, increasing the risk of:

• Miscarriages
• Preterm birth
• Fetal development issues

2. Uterine Damage

Glyphosate can alter the structure of the uterus, making it harder for embryos to implant. This disruption has been linked to:

• Endometrial hyperplasia (abnormal thickening of the uterine lining)
• Increased infertility risk
• Higher chances of early pregnancy loss

3. Ovarian Dysfunction

Studies show glyphosate exposure reduces the number and quality of eggs, leading to:

• Irregular ovulation
• Hormonal imbalances
• Lower chances of conception

4. Oxidative Stress & DNA Damage

Glyphosate increases reactive oxygen species (ROS), which cause:

• Egg and embryo damage
• Hormonal disruptions
• Weakened immune function

Additionally, glyphosate can block zinc absorption, a mineral crucial for egg development and reproductive health.

5. Genetic Changes Passed to Future Generations

One of the study’s most alarming findings is glyphosate’s ability to alter gene expression (epigenetics), meaning:

• Pregnant women exposed to glyphosate may pass down reproductive issues to their children and grandchildren.
• These changes can increase disease risks for multiple generations.

6. Hormone Disruption

Glyphosate acts as an endocrine disruptor, interfering with estrogen production. This can:

• Affect menstrual cycles
• Disrupt ovulation
• Lead to conditions like PCOS and endometriosis

Regulatory Inaction and Growing Public Concern

Despite growing evidence, the Environmental Protection Agency (EPA) continues to classify glyphosate as “safe”, even as lawsuits and independent studies link it to serious health risks.

Meanwhile, the World Health Organization’s International Agency for Research on Cancer (IARC) has labeled glyphosate as “probably carcinogenic,” adding to concerns about its long-term effects on human health.

Experts argue that more stringent regulations are needed to protect women’s reproductive health and prevent future fertility crises.

How to Reduce Your Exposure to Glyphosate

While it’s nearly impossible to avoid glyphosate completely, you can take proactive steps to lower your exposure:

• Choose organic foods – Organic crops are grown without glyphosate.
• Wash fruits and vegetables thoroughly – This removes surface residues.
• Filter drinking water – Some filtration systems can reduce glyphosate levels.
• Avoid chemical herbicides at home – Opt for natural weed control methods.
• Support organic farming initiatives – Encouraging sustainable agriculture can reduce glyphosate reliance.

A Call for Urgent Action

The study’s authors stress that glyphosate’s impact on female reproductive health is a “pressing public health issue.” They urge policymakers to:

• Fund further research into glyphosate’s long-term effects.
• Develop safer herbicide alternatives to protect fertility.
• Implement stricter regulations to limit human exposure.

With fertility rates declining and reproductive disorders on the rise, experts warn that the time to act is now—before glyphosate’s effects become irreversible for future generations.

Reference Link: https://www.alifehealth.com/press/us-fertility/

Breakthrough Research Sheds Light on Natural Mechanisms Preventing Fertilization

The study, published in the Proceedings of the National Academy of Sciences, provides key insights into the complexities of reproduction and could lead to significant advancements in both fertility treatments and contraceptive development.

How Does Fertilization Normally Work?

For fertilization to occur, sperm must recognize, adhere to, and fuse with an egg. This process relies on a specific interaction between two key proteins:

• IZUMO1 – A protein found on the surface of sperm cells.
• JUNO – A receptor on the egg that binds with IZUMO1, allowing sperm and egg fusion.

Without this crucial molecular recognition, fertilization cannot take place. However, the Yale-led study has uncovered a naturally occurring sperm antibody that can disrupt this process.

The Role of OBF13: A Natural Barrier to Fertility

First discovered in Japan four decades ago, a sperm antibody known as OBF13 was already known to interfere with fertilization. Until now, however, scientists did not fully understand how this antibody functioned at a molecular level.

Through an X-ray crystal structure analysis, Yale researchers were able to visualize how OBF13 binds to IZUMO1, changing its shape in a way that prevents sperm from successfully attaching to an egg.

The study also identified a high-affinity variant of OBF13 that is even more effective at blocking fertilization. Additionally, researchers found that certain amino acid sites on the egg’s JUNO receptor determine whether sperm can still bind to the egg despite interference from OBF13.

Major Implications for Infertility and Contraception

The discovery has far-reaching implications for reproductive health, particularly in two key areas:

1. Treating Infertility – Around 9% of men and 11% of women of reproductive age in the U.S. struggle with fertility issues. Some of these cases stem from sperm failing to bind to an egg, a process that could be disrupted by OBF13-like mechanisms. Understanding this natural blocking process could help doctors develop new therapies to enhance fertilization success in patients with unexplained infertility. 
2. Developing New Forms of Contraception – By mimicking OBF13’s ability to disrupt sperm egg binding, scientists could create non-hormonal contraceptive methods that block fertilization without affecting hormones. This could provide an alternative to birth control pills, IUDs, and other traditional contraceptives. 

“This research has direct implications for both infertility treatments and contraceptive development,” said Steven Tang, assistant professor of molecular biophysics and biochemistry at Yale and lead author of the study.

A Step Toward the Future of Reproductive Medicine

This is the first time that researchers have mapped out the structure of an anti-sperm antibody-antigen complex, a discovery that could open the door for:

• Targeted infertility treatments that enhance sperm-egg binding in cases where fertilization struggles to occur naturally.
• Non-hormonal contraceptives are designed to block sperm from fertilizing an egg, offering an alternative to traditional birth control methods.
• Drug development and screening aimed at modulating the IZUMO1-JUNO interaction for reproductive health applications.

By better understanding the molecular interactions that govern fertility, researchers may be able to develop both more effective fertility treatments for those trying to conceive and safer, hormone-free contraceptives for those who want to avoid pregnancy.

What’s Next?

With these new findings, scientists will continue to explore ways to:

• Enhance fertilization success in patients experiencing infertility.
• Develop new contraceptive methods based on OBF13’s ability to block sperm-egg fusion.
• Further, investigate other naturally occurring fertility regulators that could play a role in reproduction.

This research marks a major milestone in reproductive science, bringing new hope to individuals struggling with infertility while also paving the way for safer, more effective contraception options.

Reference Link: https://ground.news/article/how-a-naturally-occurring-mechanism-hampers-fertility

Researchers have successfully created functional sperm from pluripotent stem cells in mice, resulting in healthy, fertile offspring.

This milestone not only deepens our understanding of male fertility but also paves the way for new reproductive technologies, potentially eliminating the necessity for natural sperm production. Could this discovery mark the beginning of a future where men’s biological role in reproduction becomes optional?

Decoding Male Germ Cell Development

The formation of sperm is a highly complex process involving multiple stages:

1. Primordial Germ Cell (PGC) Formation – The earliest germ cells emerge in embryos and set the foundation for sperm development.
2. Gonocyte Transformation – These cells undergo epigenetic reprogramming, erasing inherited genetic markers to prepare for sperm production.
3. Spermatogonia Stem Cell Development – These stem cells become the foundation for lifelong sperm production.
4. Spermatogenesis – The final stage, where fully mature sperm cells capable of fertilization are produced.

While previous studies have managed to replicate the initial and final stages of sperm development in the lab, the intermediate phase—spermatogonia stem cell development—has remained a significant challenge. This phase requires precise hormonal and epigenetic conditions to ensure proper differentiation.

How Scientists Created Sperm from Stem Cells

Dr. Yukiko Ishikura and her team tackled this challenge using an innovative technique called the “reconstituted testis method.” This approach recreated the microenvironment of the testes, optimizing conditions for pluripotent stem cells to transform into spermatogonia stem cells.

After testing over 10,000 primordial germ cells in various experimental conditions, the team successfully developed spermatogonia stem cells that closely mirrored their natural counterparts. These lab-grown cells exhibited critical gene expressions and epigenetic markers, confirming their similarity to naturally occurring sperm-producing cells.

To validate their success, the scientists injected these lab-created cells into mouse testes. The cells progressed through normal spermatogenesis, producing viable spermatids. When these spermatids were used to fertilize eggs and implanted into female mice, the result was the birth of healthy, fertile offspring.

This achievement marks the first time the entire developmental pathway of male germ cells has been successfully reconstituted from pluripotent stem cells in a laboratory setting.

Implications for the Future of Fertility

The potential applications of this breakthrough are vast, spanning fertility treatments, genetic research, and reproductive technology.

1. New Hope for Male Infertility – This research could lead to innovative treatments for men with genetic conditions or medical issues that impair sperm production.
2. Revolutionizing Assisted Reproduction – Future advancements could eliminate the need for sperm donation, allowing individuals to have biological children through lab-generated sperm.
3. Understanding Genetic and Epigenetic Inheritance – By studying lab-created germ cells, scientists can explore how genetic material is passed across generations.

Professor Mitinori Saitou, Director of ASHBi, described the research as a “proof of principle” for fully replicating male germ cell development outside the body. This capability could transform fertility science and even contribute to species conservation efforts by enabling reproduction from limited genetic material.

Challenges and Ethical Considerations

Despite this promising progress, significant hurdles remain:

• Low Efficiency – The success rate of generating functional spermatogonia stem cells from pluripotent stem cells is still relatively low, requiring further optimization.
• Human Application Uncertainty – The study was conducted on mice, and it is unclear whether the same techniques can be applied to human reproductive biology.
• Ethical Implications – The ability to create sperm from stem cells raises ethical questions regarding artificial reproduction, genetic modifications, and potential misuse of the technology.

Dr. Ishikura acknowledges these challenges, emphasizing that further research is needed to refine the process and ensure safety before any potential human applications.

The Role of Stem Cells in the Future of Medicine

Pluripotent stem cells have already revolutionized medical research, offering new possibilities for regenerative medicine, tissue engineering, and disease modeling. This study demonstrates their potential to address one of the most fundamental biological processes—reproduction.

Since germ cells carry genetic information from one generation to the next, the ability to replicate sperm development in a lab could have profound implications for understanding heredity and evolution. Scientists may one day harness this technology to prevent genetic disorders, extend fertility options, or even reshape how future generations are conceived.

Conclusion: A New Era in Reproductive Science?

The successful creation of sperm from stem cells represents a groundbreaking advancement in fertility research. While the technology is still in its early stages, the potential to redefine human reproduction is undeniable.

Could we be heading toward a future where natural sperm production is no longer necessary? Although there are still many scientific and ethical questions to answer, this research has undoubtedly opened the door to unprecedented possibilities in reproductive science.

One thing is certain: the future of fertility may never be the same again.

Reference : https://ground.news/article/mens-role-in-reproduction-could-soon-become-obsolete

Low oxygen levels at high elevations can impact sperm health, leading to temporary fertility issues. While the effects are not permanent, they can take months to resolve, potentially delaying conception for couples trying to conceive. Let’s dive into the science behind this phenomenon and what it means for athletes and outdoor enthusiasts.

The Alarming Decline in Male Fertility

Sperm health has been deteriorating for decades. Experts estimate that sperm counts have halved in the last 50 years, and the trend shows no sign of stopping. <a href="https://explorersweb.com/high-altitude-sport-decreases-male-fertility/" rel="nofollow" >Male infertility is now a widespread issue, with millions of couples worldwide struggling to conceive.

Medically, a man is considered infertile if pregnancy does not occur after 12 months of regular unprotected sex. Low fertility—though not total infertility—reduces the likelihood of conception and has become increasingly common. Several medical conditions contribute to this problem, including:

• Varicocele: Enlarged veins in the scrotum, affecting 45% of infertile men.
• Sleep apnea: A sleep disorder that affects oxygen levels, impacting up to 30% of men.
• Testicular torsion: A painful condition where the spermatic cord twists, cutting off blood flow.

Now, researchers are uncovering how oxygen deprivation, a key factor in these conditions, also plays a role in fertility struggles—especially in high-altitude sports.

How High-Altitude Sports Affect Sperm Health

Engaging in activities like mountain climbing, hiking, and skiing at high altitudes exposes the body to significantly lower oxygen levels. This lack of oxygen, or hypoxia, affects various bodily functions—including sperm production.

Short-Term Effects on Fertility

Studies show that even short-term exposure to high altitudes can lead to:

• Lower sperm count – Fewer sperm are produced.
• Reduced sperm quality – Sperm motility (movement) and morphology (shape) are affected.
• Hormonal disruptions – Testosterone and other reproductive hormones may become imbalanced.

Tessa Lord, the lead researcher in the recent study, explains, “The effects on fertility are short-term but can still take a few months to resolve after returning to sea level.”

This means that men engaging in high-altitude sports who are trying to conceive may need to plan their activities carefully.

Potential Long-Term Consequences

While short-term fertility effects are well-documented, the long-term consequences remain uncertain. However, Lord’s research raises concerns about potential generational effects. Oxygen deprivation in fathers could lead to embryos with developmental issues, potentially causing fertility challenges in their offspring.

This emerging research suggests that men exposed to chronic hypoxia—whether due to medical conditions or frequent high-altitude exposure—might pass down fertility-related issues to their children.

What This Means for Athletes and Adventurers

For men who love high-altitude sports, this research doesn’t mean you have to give up your passion. However, it does highlight the importance of understanding how extreme environments affect reproductive health.

Precautions to Consider:

1. Monitor Oxygen Levels: Use wearable oxygen monitors during high-altitude activities.
2. Take Breaks: Avoid prolonged stays at extreme altitudes if trying to conceive.
3. Give Recovery Time: If fertility is a concern, allow a few months after returning to sea level before attempting conception.
4. Consult a Specialist: If struggling with fertility, consult a specialist who will assess sperm health and provide guidance.

Final Thoughts

While high-altitude sports offer breathtaking experiences and physical challenges, they also come with hidden risks to male fertility. The good news? The effects are usually temporary, and taking proper precautions can help mitigate the risks.

As research continues to explore the connection between oxygen levels and reproductive health, athletes and adventurers can make informed decisions about their activities—ensuring both their fitness and fertility remain in peak condition.

Reference : <a href="https://www.ndtv.com/world-news/high-altitude-hiking-linked-to-decline-in-fertility-among-men-study-7548750" rel="nofollow">https://www.ndtv.com/world-news/high-altitude-hiking-linked-to-decline-in-fertility-among-men-study-7548750

that for women with a lower likelihood of conception, fresh embryo transfers may lead to higher birth rates compared to frozen embryo transfers.

This finding challenges the widely adopted “freeze-all” strategy and highlights the need for more personalized fertility treatment plans. Let’s explore what this means for individuals undergoing IVF and how fertility doctors can use this research to improve outcomes.

Why Embryo Transfer Method Matters in IVF

IVF is the most common assisted reproductive technology used worldwide. The process involves retrieving eggs from a woman, fertilizing them with sperm in a laboratory, and then implanting an embryo into the uterus. Traditionally, doctors have two options:

1. Fresh Embryo Transfer: The fertilized embryo is implanted immediately after retrieval.
2. Frozen Embryo Transfer (FET): The embryo is frozen for future use, allowing doctors to optimize timing for implantation.

Many clinics have adopted the FET approach due to its flexibility and the belief that giving the body time to recover before implantation may improve success rates. However, the new study suggests that this might not be the best approach for all patients—particularly those with a lower chance of conception.

Fresh Embryos Linked to Higher Birth Rates

Researchers at Shandong University’s reproductive medical center in China conducted a study involving 838 women in their 30s who had only a few healthy eggs. Their goal was to determine whether fresh or frozen embryo transfers led to better outcomes for women with a poor prognosis.

Key Findings from the Study:

• Women who received fresh embryo transfers had a 40.1% birth rate.
• Women who underwent frozen embryo transfers had a 31.5% birth rate.
• Fresh embryo transfers also led to higher pregnancy rates and lower miscarriage rates.
• There was no significant difference in birth weight, neonatal health complications, or obstetric issues between the two groups.

According to Dr. Daimin Wei, the study’s lead researcher, determining how to best use “precious” embryos in women with lower success rates is a critical clinical question. These findings suggest that fertility doctors should consider fresh embryo transfers more often, especially for patients with a poor prognosis.

What This Means for Women Undergoing IVF

For women with fertility challenges—such as low egg count, diminished ovarian reserve, or underlying health conditions—this study offers valuable insight. Rather than following a one-size-fits-all approach, fertility clinics should take an individualized approach when choosing between fresh and frozen embryo transfers.

Factors That May Influence Embryo Transfer Decisions:

• Age – Younger women may respond differently to fresh vs. frozen transfers.
• Egg Quality – Women with fewer viable eggs may benefit from immediate implantation.
• Ovarian Response – A personalized approach based on ovarian stimulation results can improve outcomes.
• Male Factor Infertility – The study noted that male fertility issues contributed to infertility in about 17% of cases, affecting both fresh and frozen embryo groups equally.

Limitations of the Study & Future Considerations

While the study presents compelling evidence, it also has limitations. Some differences in embryo transfer timing and embryo quantity between groups could have influenced the results. More research is needed to confirm these findings in larger, more diverse populations.

Despite these limitations, the study underscores an important shift in IVF treatment strategy:
Fertility specialists should assess each patient’s unique circumstances rather than relying on standard protocols.

Final Thoughts: Personalization is Key to IVF Success

The findings from this study emphasize the importance of personalized fertility care. While frozen embryo transfers remain a viable option for many women, those with lower odds of conception may see better results with fresh embryo transfers.

If you are undergoing IVF, discuss your options with your fertility specialist. Understanding your unique fertility profile and making informed decisions about embryo transfer methods could significantly impact your chances of a successful pregnancy.

Key Takeaway:

The best IVF approach isn’t universal—personalized treatment strategies, including fresh embryo transfers, may improve birth rates for women facing conception challenges.

Reference: https://uk.style.yahoo.com/fresh-embryo-transfers-linked-higher-233338474.html

This groundbreaking tool can predict in-vitro fertilization (IVF) outcomes for men with this genetic condition, offering hope for those struggling to conceive.

Understanding the Impact of Y Chromosome Microdeletion

Male infertility is a significant issue, affecting nearly 50% of couples who face difficulty in conceiving. According to Deepak Modi, senior scientist at ICMR’s National Institute for Research in Reproductive and Child Health (NIRRCH), male infertility is often due to complications with sperm production. One of the leading causes of male infertility is Y chromosome microdeletion, which affects about 10% of men experiencing infertility.

Y chromosome microdeletion hampers sperm production, rendering many men with this condition unable to conceive naturally. As a result, men with YCMD typically require assisted reproductive technologies (ART), such as IVF, to become fathers. However, these men face additional challenges due to the genetic defect, which is inherited exclusively through the male line and leads to infertility in male offspring.

The ‘Fertility Predictor’: A Step Toward Precision in Reproductive Medicine

In response to these challenges, the ICMR and Amity University developed an advanced AI tool called the ‘Fertility Predictor.’ This AI-based tool predicts sperm retrieval rates and the success of ART procedures, such as IVF, for men with YCMD. The tool leverages machine learning algorithms to assess various factors influencing fertility, including the type of Y chromosome microdeletion present.

The ‘Fertility Predictor’ provides couples with critical data, such as the likelihood of successful sperm retrieval, fertilization, clinical pregnancy, and live birth. This predictive capability helps couples make informed decisions about their reproductive options. While the tool offers valuable insights, Dr. Modi cautioned that male babies born from IVF in men with YCMD will inherit the same genetic condition, resulting in infertility for future generations.

Developing the AI Tool: Data Collection and Validation

The development of the ‘Fertility Predictor’ took over two years of intensive research and data collection. Scientists compiled data from over 500 men diagnosed with YCMD, all of whom underwent ART treatments. Using this extensive dataset, the team applied AI and machine learning algorithms to predict IVF outcomes. After applying these algorithms, the tool was tested on another set of patients to validate its accuracy, with results showing a predictive accuracy of approximately 80%.

High Accuracy and Robust Predictions

Stacy Colaco, a scientist at NIRRCH and the first author of the study, emphasized that the ‘Fertility Predictor’ demonstrates robust accuracy, with the ability to predict both clinical pregnancy and live birth rates for men with YCMD. Abhishek Sengupta, assistant professor of biotechnology at Amity University, added that the AI tool provides numerical outputs for these key metrics, helping doctors and patients understand their chances of success with IVF.

The validation studies confirmed that the tool is highly effective, offering predictions based solely on the specific type of Y chromosome microdeletion. This level of precision enhances the decision-making process for couples and fertility specialists, improving the chances of successful ART outcomes.

The Future of Fertility Treatment

The development of the ‘Fertility Predictor‘ marks a significant advancement in the field of reproductive medicine, particularly for men with genetic infertility conditions. With a high level of accuracy, this AI tool can revolutionize the way infertility is managed, offering a more personalized and informed approach to IVF treatments.

As researchers continue to improve and refine the tool, it is expected to play an increasingly vital role in fertility care, providing couples with hope and clarity in their journey toward parenthood. However, further studies and broader application will be essential to maximize the tool’s potential and ensure that it remains a reliable resource for ART success.

Reference Link : https://theindianpractitioner.com/icmrs-ai-tool-predicts-fertility-outcomes-for-men-with-genetic-infertility/

Healthcare and Imperial College London have pinpointed that follicles sized between 13mm and 18mm are most effective for successful IVF procedures.

This large-scale retrospective study analyzed data from over 19,000 IVF patients. By employing ‘explainable artificial intelligence’ (AI), which ensures the machine learning algorithms’ findings are transparent and understandable, the team was able to draw valuable conclusions about follicle size and its impact on IVF success rates. This analysis could mark a significant step forward in personalizing fertility treatments and improving patient outcomes.

AI Ushers in a New Era for IVF Treatments

Dr. Ali Abbara, clinical scientist at Imperial College London and co-senior author of the study, explains that IVF generates an enormous amount of complex data, which often proves difficult for medical professionals to fully utilize when making treatment decisions. By integrating AI into the analysis, researchers were able to uncover patterns in the data that may have otherwise been overlooked.

“Our study has shown that AI methods are well-suited for analyzing the complexities inherent in IVF data. In the future, AI could assist doctors by providing personalized treatment recommendations, offering each couple the best possible chance of success,” said Dr. Abbara.

The study focused on patients aged 18 to 49 who had undergone IVF treatment across 11 clinics in the UK and two in Poland, using data from numerous clinics to ensure a diverse and representative sample.

The Science of Timing and Follicle Size in IVF

During IVF treatments, a hormone injection is given to trigger egg maturation in the ovaries. The precise timing of this injection is crucial to maximizing the number of mature eggs retrieved, but traditional methods have not been highly effective in determining the ideal timing for each individual patient.

Typically, the largest follicle, which may reach up to 23mm in size, signals when the trigger shot should be administered. However, this method fails to account for the sizes of smaller follicles, which may also influence egg quality and the likelihood of a successful pregnancy.

This latest study shows that a higher proportion of follicles between 13mm and 18mm is linked to a greater number of mature eggs being retrieved. This, in turn, increases the chances of a successful IVF outcome, including a higher likelihood of pregnancy and birth.

Avoiding Overstimulation for Better Outcomes

While follicle size plays a crucial role, the research also revealed that overstimulating the ovaries could have a negative effect on IVF success. Prolonged stimulation can prematurely raise levels of progesterone, a hormone associated with the development of the uterine lining, which can disrupt the IVF process.

Finding the right balance between stimulation and natural follicle development is essential, as too much stimulation can ultimately reduce the chances of a successful IVF outcome.

Future of AI in Healthcare: Improving Precision and Decision-Making

Dr. Thomas Heinis, co-senior author and expert in computing at Imperial College London, highlighted the growing importance of explainable AI in the healthcare sector. “Explainable “AI can be a valuable resource in healthcare,” said Dr. Heinis. “Given the high stakes involved in fertility treatments, this approach can support doctors in making more informed decisions and improve patient outcomes. With advances in computing power, we are on the cusp of a revolution in how we use data to personalize and optimize medical treatments.” Fertility care facilities are increasingly adopting AI technologies to enhance the precision and efficiency of treatments, offering patients more tailored and effective solutions.

The rapid evolution of AI and machine learning technologies offers hope for more precise and effective IVF procedures, paving the way for better outcomes and greater success rates in fertility treatments.

In conclusion, this study underscores the potential of AI to transform the IVF process by providing data-driven insights into follicle development, timing, and stimulation. As AI continues to evolve, its integration into IVF could lead to more successful pregnancies and healthier outcomes for patients worldwide.

Reference Link : https://www.imperial.ac.uk/news/259693/ai-could-improve-success-ivf-treatment/

and lawmakers.  What happens to the embryos left behind? Reproductive health clinics are grappling with these dilemmas, as they navigate both the technological and ethical challenges.

A Journey Through IVF: Lisa Holligan’s Story

Lisa Holligan, a UK resident, shares a familiar yet emotionally charged narrative. After two natural pregnancies, her third attempt was fraught with repeated miscarriages. Turning to IVF, Holligan and her husband successfully created six embryos. Genetic tests deemed three of them viable. Though her first attempt ended in heartbreak, the second resulted in a joyous birth—her daughter Quinn.

Today, Holligan faces an unresolved decision: the fate of her single remaining embryo, frozen for four years. Should she donate it to science, offer it to another family, or allow it to be destroyed? “We still haven’t done anything with [the embryo],” she confesses, pointing to the lack of guidance from her clinic.

The Growing Numbers in Embryo Storage

Holligan’s predicament mirrors that of millions of people worldwide. Estimates suggest that up to 10 million embryos are stored in cryopreservation tanks globally, with numbers climbing annually due to advancements in technology and increasing reliance on IVF.

In the United States alone, estimates range from 1 to 10 million frozen embryos. Globally, the figure could be exponentially higher, with some embryos stored for decades.

Ethical and Legal Challenges

Embryos hold immense potential for life, sparking moral and ethical debates. Are they merely clusters of cells, or do they possess a moral status akin to children? This question complicates decisions about their fate.

Laws governing embryo storage vary widely. In the UK, embryos can be donated, discarded, or used for research. In contrast, countries like Germany prohibit embryo freezing entirely, while Italy mandates indefinite preservation. Such disparities reflect diverse cultural, ethical, and religious values, adding to the complexity.

The IVF Boom and Its Implications

The rise in embryo storage stems largely from IVF’s growing popularity and success. Clinics stimulate egg production through hormone injections, often retrieving between 7 and 20 eggs per cycle. Once fertilized, these eggs become embryos, but not all are viable. Typically, one is implanted, and the rest are frozen.

Improved storage techniques like vitrification—a rapid freezing process—have significantly increased survival rates for embryos. In some cases, embryos have been successfully thawed and implanted decades later, as seen in a 2022 case where 30-year-old embryos resulted in healthy twins.

The Human Dilemma

Deciding what to do with unused embryos is an emotional and practical challenge. Studies reveal that 40% of individuals delay decisions for five years or more. Options like donation, destruction, or indefinite storage often feel inadequate or ethically fraught.

In countries like Spain, where IVF is relatively affordable and widely available, thousands of embryos remain abandoned. The Spanish Fertility Society reported in 2023 that of 668,082 embryos in storage, roughly 60,000 were unclaimed. Many of these belong to international patients who never return for their remaining embryos.

Toward a Solution

The burgeoning number of frozen embryos has led to rising costs and logistical challenges for clinics. Maintenance expenses, limited storage space, and the risk of human error are driving efforts to manage this issue. However, solutions remain elusive, entangled in ethical, legal, and emotional complexities. Fertility doctors are at the forefront of these conversations, seeking ways to balance patient care with the practicalities of embryo storage.

Reproductive endocrinologist Pietro Bortoletto reflects on the issue: “It’s a problem of our own creation. IVF’s success hinges on producing excess eggs and embryos, leaving us to grapple with the aftermath.”

Reference Link :  https://pmc.ncbi.nlm.nih.gov/articles/PMC11239656/

Researchers from Imperial College Healthcare and Imperial College London utilized explainable AI to analyze data from over 19,000 patients, revealing that eggs collected when follicles measure 13-18mm in size significantly improve success rates.

The findings, published in Nature Communications, emphasize how AI can personalize IVF treatment, enhancing the chances of conception and healthy births.

Understanding the Role of Follicle Size in IVF

Follicles are small sacs in the ovaries that contain eggs. During IVF, a hormone injection, known as the “trigger,” prepares these eggs for collection and fertilization. The timing of this injection is crucial; administering it when follicles are either too small or too large can reduce its effectiveness.

The research team discovered that triggering egg collection when follicles fall within the intermediate size range of 13-18mm yields the highest number of mature eggs and results in more live births. Current clinical practices primarily measure only the largest follicles, or “lead” follicles, which may overlook the potential of smaller, yet viable, follicles.

Leveraging AI for Data-Driven Decisions

The study employed explainable AI to analyze the vast datasets generated during IVF treatments. Unlike traditional methods, which focus on a limited subset of follicles, AI allowed researchers to evaluate a broader range of follicle sizes, ensuring more precise recommendations. Fertility treatment centers are now integrating this AI-driven approach to enhance the accuracy of their treatments.

Dr. Ali Abbara, co-senior author and consultant in reproductive endocrinology, highlighted the significance of AI in IVF:

“IVF produces so much rich data that it can be challenging for doctors to fully utilize it. AI offers a new paradigm in delivering IVF treatment and could lead to better outcomes for patients.”

Professor Waljit Dhillo, a co-senior author, added:

“Our findings pave the way for maximizing IVF success, leading to more pregnancies and births.”

Next Steps: Clinical Trials and AI Tool Development

The research team plans to validate their findings through clinical trials and develop an AI tool to support doctors in making data-driven decisions throughout the IVF process. This tool would integrate insights from the study, such as the optimal timing for trigger injections, to further personalize treatments.

Dr. Thomas Heinis, co-senior author from the Department of Computing at Imperial College London, emphasized the importance of explainable AI in healthcare:

“Explainable AI can support decision-making where stakes are high, ensuring better outcomes for patients.”

The Broader Implications for IVF

In addition to identifying the ideal follicle size, researchers noted that overstimulating ovaries could negatively impact the uterine lining, reducing the chances of successful embryo implantation. These insights could help refine IVF protocols, making treatments more effective and less invasive.

The study underscores the potential of AI to revolutionize healthcare, particularly in areas requiring personalized and precise interventions. With further advancements in computing power, AI-driven tools could soon become integral to reproductive medicine, offering new hope to couples facing infertility challenges. Reproductive endocrinologists are expected to benefit significantly from these innovations, as AI enables more informed, individualized care for patients.

Future for IVF

One in six couples experiences infertility, and IVF remains a beacon of hope. However, the process is often emotionally, physically, and financially taxing. By harnessing the power of AI, researchers are making strides to improve success rates, minimize risks, and ensure every patient receives the best possible care.

As clinical trials progress and AI tools are developed, the integration of data-driven insights into IVF treatments promises to redefine the landscape of reproductive medicine, offering brighter prospects for families worldwide.

Reference Link : https://www.nihr.ac.uk/news/ivf-success-could-be-increased-using-ai-tools?

the chances of conception, offering  hope to individuals and couples navigating the emotional and financial challenges of infertility. 

A Miracle for Patients

Elena, a 36-year-old from South London, became the first woman in the UK to conceive through a fully AI-guided IVF process. After years of failed attempts, she is now 23 weeks pregnant and credits this groundbreaking technology with her success. “The technology is incredible. It feels like a miracle,” she shared.

AI selected the strongest sperm from her husband and the most viable embryos for implantation, significantly increasing her chances of a successful pregnancy.

The Science Behind AI in IVF

Traditional IVF relies on subjective human judgment to assess sperm and egg quality, often leading to inconsistent outcomes. AI, trained on vast datasets including ultrasound images and patient health metrics, revolutionizes this process by providing precise, real-time evaluations. IVF centers now utilize this technology to enhance the accuracy and efficiency of fertility treatments.

Dr. Jyoti Taneja, medical director at Avenues Fertility Clinic in North London, explained how AI evaluates sperm health by analyzing movement patterns and other critical factors. It also assesses eggs for maturity, shape, and size, predicting their likelihood of conception. “This meticulous approach not only improves outcomes but also minimizes unnecessary interventions,” Dr. Taneja said. IVF specialists can now rely on AI-driven insights to make more informed decisions for their patients, leading to better treatment success rates.

Transforming Lives

Laura Farrell, 34, from Peterborough, is another success story. After three miscarriages and a series of health complications, she turned to AI-driven IVF. The technology selected her healthiest embryo, leading to a successful pregnancy on the first attempt.

“Infertility is an awful experience,” Laura shared. “The tailored treatment I received was fantastic, and the advanced AI technology made all the difference.”

Broader Implications for Fertility Treatment

Fertility challenges affect one in six couples, with over 50,000 IVF procedures conducted annually in the UK. However, success rates remain modest, with only one in three women conceiving after their first cycle.

AI offers a game-changing solution. By improving embryo selection, AI reduces the physical, emotional, and financial toll of repeated IVF cycles.

Professor Simon Fishel, a pioneer in IVF, acknowledged AI’s potential, stating, “If AI can increase the chances of healthier outcomes, it’s an exciting development. But more research is needed through controlled trials to validate its long-term impact.”

Future of Fertility Care

AI’s applications extend beyond IVF. Clinics are now using AI to match surrogates with intended parents and optimize hormone injections for egg preparation, further enhancing the success rates of fertility treatments.

Dr. Ali Al Chami, a leading consultant, believes AI is ushering in a new era of reproductive medicine. “In five years, AI will be a standard tool in all fertility clinics,” he predicted.

Despite its promise, experts like Professor Geeta Nargund stress the need for increased public funding and equitable access to fertility care. “We must end the postcode lottery of treatment to ensure everyone benefits from these advancements,” she emphasized.

A Hopeful Future

AI is transforming fertility care, bringing new hope to individuals and couples facing infertility. By selecting the healthiest sperm and eggs, this advanced technology significantly increases IVF success rates while reducing emotional and financial strain. As research continues, AI’s applications are expanding, from optimizing embryo selection to improving hormonal treatments and matching surrogates with intended parents.

Experts believe that within a few years, AI will become a standard tool in fertility clinics worldwide, revolutionizing reproductive medicine. This innovation promises to make parenthood more achievable, offering millions the chance to overcome fertility challenges and realize their dreams of having a family.

Reference Link : https://www.thesun.co.uk/tech/32761128/artificial-intelligence-helping-women-ivf-pregnant/

Tackling Infertility with AI

Infertility affects one in six couples worldwide, and in 2022 alone, 52,500 individuals underwent IVF treatment. However, success remains elusive for many, with only a third of women under 34 achieving a successful birth per cycle using their own eggs. For women aged 43 to 44, success rates plummet to just 5%.

The financial and emotional toll of multiple IVF cycles is significant, but advancements in AI are offering a glimmer of hope. By integrating AI technology into IVF clinics, the process is becoming more precise and efficient.

Inside a High-Tech IVF Clinic

At the Avenues Clinic in London, AI has become an integral part of the IVF process. Dr. Jyoti Taneja, the clinic’s medical director, highlights the transformative role of AI. “AI evaluates sperm, eggs, and embryos, identifying the healthiest candidates for fertilization and implantation,” she explains.

During a demonstration, sperm samples are analyzed on-screen, with AI assigning grades like ‘A,’ ‘B,’ or ‘C’ to individual sperm. This not only saves embryologists hours of manual work but also minimizes the risk of miscarriage and abnormalities, improving outcomes for hopeful parents.

Real Stories: AI in Action

Laura Farrell, a patient at the Avenues Clinic, shared her experience with AI-assisted IVF. After transferring her embryos from another clinic, the AI software was used to select the healthiest embryo. Now nine-and-a-half weeks pregnant, Laura calls the technology “fantastic” and urges women to consider AI integration when choosing an IVF clinic.

However, she also highlights barriers to accessing IVF. “The high costs and discriminatory policies, like denying NHS support to single women, remain significant challenges,” she said. Laura believes AI could make a difference by improving first-cycle success rates, thus reducing financial strain.

Balancing Technology and Expertise

Despite the optimism, experts urge caution in embracing AI without thorough validation. Consultant Ali Al Chami from the Avenues Clinic emphasizes that AI complements medical expertise rather than replacing it.

“AI supports decision-making by analyzing patient history and treatment data, but final decisions rest with doctors and embryologists,” Al Chami explains. He believes that as the technology evolves, it will bring greater clarity and efficiency to IVF.

A Promising Future

Dr. Ali Abbara, a leading consultant at Imperial College Healthcare NHS Trust, believes AI has the potential[ez-toc] to make IVF more accessible by driving down costs and enhancing efficiency. However, he stresses the need for robust clinical data before widespread adoption.

“It’s essential to demonstrate the effectiveness of AI and optimize the technology before rolling it out on a larger scale,” Dr. Abbara cautions.

Conclusion

While still in its early stages, AI is showing great promise in transforming IVF treatment. From improving success rates to potentially making the process more affordable, AI is poised to reshape the future of fertility care. For couples navigating the challenging path of infertility, this technological breakthrough offers renewed hope for building their families.

Reference news Link : https://www.imperial.ac.uk/news/259693/ai-could-improve-success-ivf-treatment/ 

On the other hand, AIDS is the final stage of HIV, characterized by a severely weakened immune system.

HIV primarily targets CD4 cells—white blood cells critical for immune response. Over time, the virus compromises the body’s defenses, making it vulnerable to severe infections and diseases. HIV spreads through bodily fluids like blood, semen, vaginal secretions, and breast milk but cannot be transmitted via air, water, or casual physical contact. For individuals affected by HIV and related concerns, consulting specialists in reproductive health can provide important guidance on managing reproductive health and fertility.

Without treatment, HIV progresses into AIDS within a decade. However, antiretroviral therapy can help people with HIV lead long, healthy lives, preventing progression to AIDS.

HIV/AIDS and Fertility: How Are Men and Women Affected?

HIV and AIDS can significantly impact fertility in both men and women.

• Effects on Men

HIV-positive men often experience hormonal imbalances, leading to reduced sperm motility, concentration, and structural abnormalities. Opportunistic infections like orchitis and prostatitis can damage reproductive organs, while conditions such as erectile dysfunction, ejaculatory dysfunction, and lowered libido are common in up to 60% of patients.

• Effects on Women

In women, HIV reduces fertility by 26%. Hormonal imbalances can lead to irregular menstrual cycles, disrupting ovulation. The risk of pelvic inflammatory disease (PID) increases, potentially causing fallopian tube scarring and impaired conception. HIV may also accelerate ovarian aging, reducing ovarian reserves and advancing perimenopause.

Moreover, antiretroviral medications can affect sperm and egg quality, further influencing fertility outcomes.

Pregnancy and HIV/AIDS: Key Considerations

For HIV-positive individuals, pregnancy comes with unique challenges. The risk of transmitting HIV to the baby exists during pregnancy, childbirth, or breastfeeding. This vertical transmission risk is low—less than 2% with proper precautions—but requires careful management.

Reducing Transmission Risks

• If the male partner is HIV-positive, sperm washing can remove viral particles before reproductive treatments.
• Antiretroviral therapy is crucial for HIV-positive mothers to minimize the risk of transmission to the baby.

Early Symptoms of HIV and AIDS

Early signs of HIV can resemble flu symptoms, including fever, chills, sore throat, skin rashes, and swollen lymph nodes. If untreated, HIV progresses to AIDS, characterized by opportunistic infections, chronic diarrhea, neurological issues, rapid weight loss, and skin abnormalities. For individuals seeking assistance with reproductive health during HIV treatment, consulting infertility care clinics can offer valuable support and guidance.

With timely antiretroviral treatment, many HIV-positive individuals can maintain their health and even plan for parenthood with minimal risks.

Supporting HIV-Positive Couples on Their Parenthood Journey

For couples affected by HIV, achieving parenthood is possible with medical support. Advanced fertility treatments, combined with antiretroviral therapy, can help minimize risks and address fertility challenges. Reproductive specialists can provide personalized care to ensure a safe pregnancy and delivery.

Bottom Line

HIV/AIDS significantly impacts fertility and reproductive health, but medical advancements have made it possible for affected individuals to manage these challenges effectively. By seeking timely medical support and adhering to treatment protocols, HIV-positive individuals and couples can achieve their dreams of parenthood.Refrence link:  https://www.clinicatambre.com/en/last-news/hiv-and-fertility-all-you-need-to-know

and environmental toxins extend far  beyond respiratory or ecological harm—they now threaten fertility and reproductive well-being across generations.

Dr. Kshitiz Murdia, highlights the critical connection between environmental changes and reproductive health. The implications are significant for both men and women, with alarming evidence suggesting that pollution and climate-induced factors could hinder fertility.

Pollution: A Major Fertility Risk

Airborne pollutants, such as fine particulate matter (PM2.5 and PM10), pose a serious threat to reproductive health. These pollutants, alongside high carbon dioxide levels, can disrupt fertility in both sexes. Male fertility appears particularly vulnerable. A study published in the British Medical Journal found that men aged 30-45 exposed to elevated PM2.5 levels for five years faced a 24% higher risk of infertility.

Women are also affected. Rising pollution levels contribute to reduced ovarian reserves and impaired egg quality. Additionally, air pollution increases risks for pregnant women, with links to complications such as high blood pressure, premature delivery, low birth weights, and even developmental issues affecting fetal brain and lung formation.

Heat and Hormonal Disruptions

Beyond air pollution, rising global temperatures introduce further challenges. Scientific evidence connects prolonged heat exposure with higher rates of premature births and infant mortality. Pregnant women are particularly susceptible, with increased risks of placental issues, gestational diabetes, hypertension, and pregnancy loss due to temperature fluctuations.

Environmental toxins also disrupt hormonal health, impacting menstrual cycles. Research in the International Journal of Environmental Research and Public Health shows that these toxins can alter the timing of menstruation. Early onset of menstruation is linked to reproductive challenges, cardiovascular diseases, and a higher risk of breast cancer. On the other hand, delayed onset can lead to fertility struggles and reduced bone density in later life. For those facing fertility challenges, seeking advice from infertility specialists can provide valuable insights and guidance

A Call to Action

The intricate relationship between environmental factors and reproductive health underscores the urgent need for global action. Women and children are particularly vulnerable to these risks, making it imperative to address these issues through robust environmental policies and healthcare strategies.

Experts stress the importance of coordinated efforts to mitigate environmental harm, enhance public health initiatives, and safeguard reproductive wellness for current and future generations. Tackling the impacts of climate change on fertility requires collective action, prioritizing both ecological sustainability and human health.

Reference link:  https://www.indiraivf.com/blog/impact-of-environmental-factors-on-fertility

success rates and reduce treatment costs, experts warn it could have unintended ethical and social consequences.

Ethical Concerns in AI-Assisted Embryo Selection

A recent paper published by the European Society of Human Reproduction and Embryology raises critical bioethical concerns about AI’s growing role in fertility treatments. Researchers argue that allowing machine learning to make decisions about “who is brought into the world” without robust ethical oversight could erode trust in fertility clinics.

Professor Catherine Mills, head of Monash University’s Reproduction in Society research group and a co-author of the study, emphasized the lack of transparency surrounding AI usage in IVF. She noted that many patients and their partners might be unaware that AI algorithms are influencing decisions about embryo selection or how these algorithms were developed and trained.

Risks of Bias and Unintended Consequences

The paper highlights the potential for unintended bias in AI systems used in fertility clinics. For example, machine learning algorithms may perform better for certain demographic groups, such as specific ethnicities, than others. This could lead to inequities in treatment outcomes.

Additionally, there is concern that AI might inadvertently consider factors patients would find inappropriate, such as embryo sex or traits linked to a higher likelihood of implantation. These unintended consequences could lead to ethical dilemmas and reduced trust in the technology.

Growing Adoption in Australia’s Fertility Industry

Australia’s fertility industry is rapidly expanding, with revenue estimated at $1.49 billion in 2023 and projected to reach $1.63 billion by 2030. AI is already being implemented in some clinics to streamline embryo selection processes and improve outcomes. However, the extent of its use remains unclear.

“Some clinics are using it; there is empirical evidence that AI is being applied routinely,” Professor Mills explained. “We anticipate it will become more widespread.”

AI Trials and Future Implications

One national fertility provider, Virtus Health, recently conducted clinical trials to evaluate the predictive capabilities of AI in assessing embryo development. The technology aims to increase the likelihood of successful pregnancies while minimizing time and financial burdens for patients. Despite these benefits, questions about ethical governance and patient awareness persist.

Navigating the Path Ahead

As AI becomes a central player in fertility treatments, experts call for greater transparency, regulation, and public engagement. Without ethical oversight, the integration of AI could risk dehumanizing an intensely personal process and diminish trust between patients and fertility clinics.

While the promise of AI in IVF is undeniable, its use must be guided by a commitment to fairness, inclusivity, and respect for patients’ values. Only then can the full potential of this groundbreaking technology be realized without compromising ethical standards.

Reference Link:  https://bioethics.com/archives/95449

these developments as transformative for individuals and couples seeking to conceive. 

Enhanced Diagnostic Techniques

Advancements in radiological procedures have improved the diagnosis of reproductive health issues. Previously, certain conditions required invasive surgical procedures for diagnosis; now, enhanced imaging technologies allow for accurate, non-invasive assessments, streamlining the path to effective treatment.

Genetic Testing of Embryos

Pre-implantation genetic testing (PGT) has become a pivotal tool in fertility treatments. This technique enables the analysis of embryos for chromosomal normalcy and specific genetic disorders before implantation. Currently, PGT can identify embryos with normal chromosome counts and determine their gender. Additionally, it can detect hereditary diseases, such as cystic fibrosis or Huntington’s disease, especially when both parents are carriers of recessive traits.

Looking ahead, advancements in genetic testing may allow for the assessment of an embryo’s predisposition to complex conditions like hypertension, diabetes, or heart disease. Such capabilities would enable prospective parents to select embryos with the lowest risk profiles, potentially reducing the incidence of these multifactorial diseases in future generations.

CRISPR and Gene Editing

The advent of CRISPR technology introduces the possibility of correcting genetic abnormalities at the embryonic stage. While still experimental and not yet approved for human use, CRISPR holds promise for excising defective gene segments, thereby preventing the transmission of genetic disorders. As research progresses, this technology could become a cornerstone of fertility treatments, offering solutions to previously intractable genetic issues.

Ethical Considerations and Social Media’s Role

The dissemination of fertility-related information via social media presents both opportunities and challenges. Dr. Werlin emphasizes the importance of combating misinformation by providing accurate, reliable content and encourages individuals to consult healthcare professionals for personalized advice. Ethical considerations also arise regarding the sharing of personal and professional experiences in the fertility field, underscoring the need for sensitivity and confidentiality.

The landscape of fertility treatments is rapidly evolving, offering hope to many aspiring parents. From enhanced diagnostic tools and sophisticated genetic testing to the potential of gene editing technologies like CRISPR, the future holds promising possibilities beyond traditional IVF. As these technologies advance, they bring the prospect of healthier outcomes for future generations, while also prompting important ethical discussions within the medical community.

Reference link:  https://www.havingbabies.com/dr-lawrence-werlin-interviewed-pharmaceutical-executive/

reproductive health, and life expectancy.  This comprehensive review illuminates the genetic underpinnings that influence when individuals start families, the timing of menopause, and the broader implications on longevity. This study is closely related to research on fertility clinics, which focus on assisting individuals and couples with reproductive health.

Genes at the Core of Reproductive Health

The study utilized the GWAS Catalog, a robust online database of Genome-Wide Association Studies (GWAS), to compile findings from 159 genetic studies. Researchers identified 37 key genes linked to crucial reproductive traits such as age at first childbirth, timing of menopause, and levels of reproductive hormones like follicle-stimulating hormone (FSH) and testosterone. Among these, the FSHB gene (follicle-stimulating hormone subunit beta) emerged as particularly influential, linked to eleven different reproductive outcomes including the regulation of menstruation and menopause.

Broader Health Implications

These genetic factors not only dictate reproductive timelines but also have broader health implications. “Our research integrates findings across the genetics of reproduction to uncover common genes that influence traits extending beyond fertility, including health, body mass index (BMI), hormone-sensitive cancers, and even behavioral traits,” explained Professor Melinda Mills, the study’s senior lead author and Director of the Leverhulme Center for Demographic Science.

Connections to Longevity and Disease

The study also highlights the connection between reproductive genes and longevity. For instance, the ESR1 gene, which influences estrogen receptor function, is associated with reproductive traits that correlate with both hormone-sensitive cancer risks and longer life spans. Additionally, traits like early puberty onset or later menopause were linked to an increased risk of breast cancer, yet also associated with longer overall life expectancy.

Focus on Male Fertility

Historically, female reproductive health has garnered more research attention, but this study also sheds light on male reproductive genetics. Genes like DNAH2 are crucial for testosterone levels and sperm function, underscoring the importance of male reproductive health in overall fertility. “Exploring the genetics of male infertility opens up new avenues for treatments and a deeper understanding of reproductive challenges,” stated Vincent Straub, co-author and DPhil student at the Leverhulme Center. This research highlights the critical role of fertility specialists in addressing male infertility issues.

Generational Genetics

The review goes beyond individual health to consider how genetic changes influence future generations. Parents accumulate de novo mutations—new, spontaneous genetic changes—as they age, which can significantly impact their offspring’s health and development. These findings underscore the complex interplay between genetics and reproductive health across generations.

Implications for Personalized Healthcare

This study not only broadens our understanding of reproductive genetics but also sets the stage for more personalized approaches in healthcare. By identifying genetic factors that influence fertility and longevity, medical professionals can better predict and manage individual health trajectories. “This research provides crucial insights that could revolutionize personalized healthcare, improving outcomes for individuals and families,” concluded Dr. Stefanía Benónísdóttir, first author and Postdoctoral Researcher.

As genetic research continues to evolve, its impact on understanding and managing reproductive health promises to enhance the quality of life and inform healthcare strategies for generations to come. 

Reference link: https://medicalxpress.com/news/2024-12-dna-reproductive-health-fertility-life.html

(IVF), is proving to be a game-changer  With its robust analytical capabilities, AI is empowering fertility specialists to enhance embryo selection, tailor treatment plans, and monitor patient progress with unprecedented precision. This leap in technology is not only elevating success rates but also alleviating the emotional burden on couples striving to conceive.

Dr. Hrishikesh Pai’s Pioneering Work

Dr. Hrishikesh Pai, a leading IVF expert and the Founder and Medical Director of Bloom IVF Group, has been at the forefront of incorporating AI into fertility treatments. With over four decades of experience, Dr. Pai’s efforts have centered on refining fertility care using AI to offer personalized treatment solutions. “AI is reshaping the approach to fertility treatments by enhancing our decision-making process with precise, data-driven insights,” says Dr. Pai.

AI-Enhanced Embryo Selection

A crucial application of AI in IVF is in the selection of embryos. AI algorithms analyze high-resolution images to assess embryo quality and viability with greater accuracy than ever before. This capability is vital, especially for patients who have previously experienced unsuccessful IVF cycles. “AI enables us to detect subtle indicators within embryos, significantly boosting the likelihood of success,” explains Dr. Pai.

Personalizing Fertility Treatments

AI’s ability to process complex datasets, including medical histories, hormonal levels, and genetic information, allows clinicians to customize treatment protocols to the individual needs of patients. This personalization is crucial in enhancing treatment efficacy and optimizing outcomes.

Real-time Monitoring and Proactive Adjustments

Advanced AI systems are now capable of real-time monitoring of patients’ treatment progress, providing a detailed view of vital parameters. This functionality enables fertility specialists to make proactive adjustments to treatment plans, thereby improving the chances of a successful pregnancy.

The Future: Predictive Simulations and Access Expansion

Looking ahead, AI is set to revolutionize fertility care further. Dr. Pai anticipates the use of AI to simulate entire IVF cycles, which would allow for the prediction and optimization of treatment strategies without the need for trial and error. Additionally, AI has the potential to democratize access to advanced fertility treatments, making them more affordable and accessible to a broader audience, including those in underserved regions.

Enhancing Patient Experience

The use of AI also contributes to a better patient experience by reducing uncertainties associated with IVF. Patients benefit from a more informed and transparent treatment process, where every step is backed by reliable data, reducing anxiety and building trust in the treatment process.

Conclusion: A New Era in Fertility Care

As AI continues to evolve, its integration into fertility care promises not only to refine the technical aspects of treatments like IVF but also to transform the patient experience fundamentally. “AI is not just enhancing our clinical practices; it’s revolutionizing how we support couples on their journey to parenthood,” Dr. Pai reflects. With AI, the future of fertility care looks more hopeful, with the potential to turn dreams of parenthood into reality for many more couples around the world.

This shift towards AI-driven fertility solutions underscores a pivotal shift in healthcare—embracing technology to improve not only outcomes but also the comprehensiveness and compassion of care provided to patients navigating the challenging journey of infertility.

Reference Link:  https://www.sciencedirect.com/science/article/pii/S0015028223005204

This innovative technology aims to provide a less invasive alternative for treating infertility caused by tubal obstructions.

A Minimally Invasive Approach

Fallopian tube blockages, which account for approximately 30% of infertility cases in women, prevent sperm from reaching the egg and can also lead to ectopic pregnancies, which are potentially life-threatening. The current treatment for such blockages typically involves surgery or the use of catheters and guidewires, which can be quite invasive.

The new micro-robot, constructed from a non-magnetic photosensitive resin and coated with a thin iron layer, offers a groundbreaking solution. “This new technology offers a potentially less invasive alternative to traditional surgical methods,” said Haifeng Xu. The robot’s design allows it to be controlled via an external magnetic field, enabling it to rotate and move forward through the fallopian tubes to clear obstructions effectively.

Trials and Future Prospects

So far, the device has been tested in glass tubes that mimic the structure of fallopian tubes, where it successfully cleared away cell clusters that simulate the blockages found in human patients. These promising results have spurred the team to plan further development of an even smaller version of the robot for live testing in organ models and animals.

Addressing a Critical Need

Blockages in the fallopian tubes can be caused by a variety of factors, including infections like chlamydia, inflammation, fibroids, or endometriosis. Often, women with blocked tubes do not exhibit any symptoms and might only discover the issue when trying to conceive. While traditional diagnostics involve X-rays or ultrasound, and treatments may extend to keyhole surgery or IVF, the micro-robot represents a significant advancement in terms of invasiveness and patient comfort.

Beyond Fertility

Looking ahead, the potential applications of this micro-robot extend beyond clearing fallopian tube blockages. “The ultimate goal is to provide a more effective, minimally invasive solution for patients suffering from infertility,” Xu emphasized. Additionally, the technology could potentially be adapted to address other types of blockages within the body, paving the way for broader medical applications.

This development not only highlights the innovative use of micro-robotics in medicine but also offers renewed hope to countless individuals facing the challenges of infertility. As research progresses, the potential for this technology to transform treatment approaches in reproductive health and beyond continues to grow.

Reference link:

https://www.cnbctv18.com/technology/new-fertility-technology-leads-to-successful-birth-of-first-robot-conceived-babies-in-us-16506621.htm   

This breakthrough, known as Fertilo, leverages stem cells to enhance embryo maturity outside the human body, presenting a promising alternative to traditional in vitro fertilization (IVF) methods.

The Evolution of IVF and Introduction to Fertilo

Since Louise Brown, the first ‘test tube baby,’ was born in 1978, IVF has become a beacon of hope for millions facing fertility challenges. However, despite its success, conventional IVF has its drawbacks, including long treatment cycles and significant physical and emotional strain. Enter Fertilo: a technique refined by the female-led biotech firm Gameto, which aims to revolutionize women’s reproductive health by addressing these challenges.

The Science Behind Fertilo

Fertilo distinguishes itself by employing ovarian support cells (OSCs) derived from human induced pluripotent stem cells (iPSCs). These cells are co-cultured with immature eggs to mimic natural egg maturation in a lab setting. This innovative approach not only reduces the hormonal burden but also significantly shortens the treatment cycle to just three days. A 2023 study confirmed the efficacy of this method, noting marked improvements in egg maturation and embryo formation.

Benefits of the New Method

Dr. Dina Radenkovic, CEO and co-founder of Gameto, elaborates on the advantages of Fertilo, highlighting its ability to mitigate the major pitfalls of conventional IVF such as the emotional and physical toll on patients, and the extensive use of hormone injections which can lead to conditions like ovarian hyperstimulation syndrome. By minimizing these aspects, Fertilo offers a safer, faster, and more accessible fertility treatment option.

Global Adoption and Future Prospects

Following its initial success, Fertilo has gained regulatory clearance in several countries, including Australia, Japan, and various nations in Latin America, with plans underway for Phase 3 trials in the United States. This expansion is a testament to the technology’s potential and Gameto’s commitment to broadening access to innovative reproductive solutions.

Personal Stories of Hope

The significance of Fertilo extends beyond scientific achievement, touching lives on a very personal level. The mother of the first Fertilo baby shared her relief at choosing a method that reduced the number of injections and provided a gentler approach to egg retrieval. Her positive experience underscores the method’s potential to alleviate the burdens typically associated with fertility treatments.

Conclusion

As Fertilo continues to make inroads across the globe, it not only offers a new hope for couples struggling with infertility but also stands as a pioneer of the next generation of reproductive technologies. With its blend of advanced science and patient-centered care, Fertilo could soon redefine the landscape of fertility treatments worldwide.

This milestone not only marks a significant advancement in reproductive health technology but also ignites a new era of hope for countless individuals aspiring to parenthood under challenging conditions.

Reference link: https://pmc.ncbi.nlm.nih.gov/articles/PMC1129084/

have become increasingly common.  This trend sees many facing natural declines in reproductive capacity during their late 30s and 40s—a critical period when conception becomes more difficult and risks associated with pregnancy rise. A recent comprehensive review in Nature Aging brings attention to innovative therapies and technologies that could potentially counteract these declines.

Understanding Reproductive Aging

Female Fertility Concerns: Women experience a significant reduction in fertility as they age, marked by a diminished ovarian reserve and the declining health of remaining oocytes. Age-related changes such as mitochondrial dysfunction and chromosomal anomalies in eggs contribute to decreased fertility. Furthermore, ovarian fibrosis, characterized by an increase in collagen and inflammation, severely impacts follicle development and ovulation.

Male Fertility Challenges: Similarly, men over 40 face a gradual decline in fertility, with decreased sperm quality and increased DNA damage, which affect embryo quality and increase miscarriage risks. Aging in men is also marked by reduced testosterone levels, which impair sperm production and overall reproductive function.

Innovative Therapeutic Approaches

For Women: The market offers various supplements purported to enhance fertility, but evidence of their effectiveness remains limited. Notably, compounds such as Coenzyme Q10 and melatonin show promise in preliminary studies for improving mitochondrial function and reducing oxidative stress in oocytes. Additionally, developments in pharmaceuticals like Metformin and novel compounds like BGP-15 offer hope in enhancing follicular health and extending reproductive longevity.

For Men: Emerging treatments for male reproductive aging include antioxidants like idebenone and melatonin, which help mitigate oxidative stress in sperm cells, potentially improving both motility and embryo development. Hormonal therapies aimed at boosting testosterone production are also being explored to improve sperm production and quality.

Revolutionary Assisted Reproductive Technologies (ART)

ART remains a pivotal option for those confronting age-related infertility. Techniques such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) are routinely used, though their success rates tend to decrease with patient age due to poorer oocyte quality. Cutting-edge methods like Mitochondrial Replacement Therapy (MRT) and In Vitro Gametogenesis (IVG) represent the frontier of fertility treatments, aimed at rejuvenating egg quality and generating viable oocytes from somatic cells, respectively.

The Promise of Experimental Strategies

While mitochondrial treatments and other experimental methodologies offer a glimpse into potential future successes in combating age-related fertility issues, these technologies are still in their infancy. Comprehensive clinical trials and ethical considerations are necessary to ensure their safety and efficacy for widespread use.

Conclusion and Future Outlook

The research underscores the critical need for validated, effective treatments for age-related fertility decline. As these experimental approaches continue to develop, they offer a beacon of hope for many who wish to extend their reproductive years. With continued research and rigorous testing, the future could see these promising therapies providing viable solutions for those facing the challenges of later-life parenthood.

Published in the journal Environment International, this research provides a detailed examination of how pollutants impact both sperm and eggs during the fertilization process.

IVF and the Role of Environmental Factors

IVF involves extracting eggs and fertilizing them outside the body before implanting them back into the patient. Despite advancements in reproductive technologies, the overall success rates of IVF are relatively low, often under 50%. This study suggests that environmental factors, such as air quality, could play a crucial role in these success rates.

Analyzing the Impact on Eggs and Sperm

The study’s methodology was particularly innovative in its approach to separating the effects of air pollution on reproductive cells. Researchers utilized air quality data from the Environmental Protection Agency, correlating it with the developmental stages of eggs and sperm used in IVF. They focused on the periods of ovarian stimulation and the crucial 72-day development period for sperm. The findings showed that higher levels of air pollutants correlate with lower egg survival rates, reduced embryo quality, and decreased fertilization success, particularly noticeable during the egg thawing process.

Unique Insights from Donor Eggs

By using donor eggs in their research, scientists were able to distinguish the specific impacts of air pollution on eggs and sperm, considering their development in different environmental conditions. “Understanding the dual impact on both types of reproductive cells opens new paths for research, especially into the effects of air quality on male fertility,” noted Sarah LaPointe, the study’s lead researcher.

The Significance of Organic Carbon

One of the significant findings of the research was the consistent negative effect of organic carbon, part of PM2.5 air pollution, on reproductive outcomes. PM2.5 particles are extremely fine pollutants primarily generated by vehicle emissions and wildfires, known for their ability to penetrate deep into the lungs and enter the bloodstream.

Future Directions and Multi-Pollutant Analysis

While the current study focused on individual pollutants, researchers acknowledge the limitation of not examining the combined effects of multiple pollutants. Plans for future studies include a more comprehensive multi-pollutant analysis to better understand how mixed air pollution exposures might influence IVF results.

Broader Implications for Public Health

This research is particularly timely, given that nearly 40% of Americans live in areas with detrimental levels of particulate pollution or ozone, disproportionately affecting communities of color. “These findings underscore the importance of environmental health in reproductive success and the need for comprehensive public health strategies to improve air quality,” commented Mary Willis, an external epidemiologist.

Importance of Including Men in Fertility Health Discussions

The study also makes a case for more inclusive health recommendations that consider the environmental exposures of men, not just women, during fertility treatments. This shift could lead to better outcomes for couples undergoing IVF by mitigating some of the environmental risks involved.

This pivotal research highlights the critical intersection of environmental science and reproductive health, suggesting that improving air quality could enhance the success rates of IVF treatments, offering hope to many who rely on these procedures to start a family.

Ref link: https://www.bbc.com/news/articles/c785mkm39ndo

festivities can add an unseen layer of stress for those navigating fertility issues. Here’s how to handle the festive season with grace and calm while on your journey to parenthood.

Prioritize Your Emotional Well-being

First and foremost, it’s crucial to prioritize your emotional health. The pressure of fertility struggles can be magnified during a period where family and children are central themes. Allow yourself to feel and express your emotions in a healthy way. It’s okay to skip an event if you feel it might be too overwhelming.

Communicate with Your Partner

The holiday season is a perfect time to strengthen your bond with your partner. Discuss your feelings, apprehensions, and how you’d like to handle certain situations, such as answering the inevitable “When are you going to have kids?” question. Being on the same page with your partner can provide a significant emotional buffer against the stress of holiday gatherings.

Setting Boundaries with Family and Friends

It’s important to set boundaries with family and friends. Decide in advance how much (or little) you will share about your fertility journey. It’s perfectly acceptable to tell people that you’d prefer not to discuss your private life. Most will respect your wishes, and having a prepared response can ease the anxiety of being asked personal questions.

Maintain Healthy Habits

The holidays can tempt us to overindulge, but if you’re trying to conceive, it’s wise to stick to healthy habits. Enjoy the festivities, but be mindful of your health by maintaining a balanced diet, keeping active, and limiting alcohol. Also, ensure you’re getting enough rest amidst the busy season to help your body stay regulated and healthy.

Seek Support

Whether it’s from a counselor, a support group, or trusted friends, having a support system can be invaluable. Connecting with others who are going through similar experiences can provide comfort and tips on how to cope during the holidays.

Create New Traditions

If traditional holiday activities are too painful this season, consider creating new traditions with your partner or close friends. Whether it’s a quiet getaway or a new activity that doesn’t revolve around children and extended families, finding your unique way to celebrate can create new joyful experiences without the stress of past expectations.

Focus on the Meaning of the Season

Finally, try to reconnect with what the holiday season means to you beyond external expectations. Whether it’s a time for spiritual growth, reflecting on gratitude, or just being present in the moment, focusing on these aspects can help restore your peace and joy during Christmas.

Navigating Christmas while trying to conceive requires a blend of open communication, self-care, and adjusting expectations. By focusing on what truly matters to you during the season, you and your partner can still find joy and meaning while on your journey to parenthood. Remember, it’s about making the season special in a way that feels right and fulfilling for you both.

Reference Link – https://www.fertilityfamily.co.uk/blog/how-to-navigate-christmas-when-trying-for-a-baby/

from Suffield, Connecticut, experienced firsthand the challenges of conceiving, which she believes were linked to synthetic chemicals in her home products.

Making a Change at Home

After failing to conceive naturally and learning of her ovarian dysfunction, Phillips decided to eliminate scented candles, body washes, moisturizers, and other scented products from her home. This decision was influenced by discussions in online groups and supported by scientific research suggesting that these products contained potentially harmful endocrine-disrupting chemicals. Remarkably, Phillips conceived her first child via artificial insemination and later had a natural pregnancy, leading her to advocate for awareness about chemical exposure.

Scientific Concerns and Legal Actions 

Endocrine disruptors, as these chemicals are known, interfere with hormone functions critical for reproduction. Found in a myriad of consumer products—from plastics and cosmetics to waterproof clothing—these chemicals are increasingly scrutinized for their health impacts. Texas recently took legal action against manufacturers for falsely advertising the safety of these chemical-laden products, highlighting the growing concern over their reproductive effects.

Industry Response and Regulatory Challenges 

The American Chemistry Council maintains that everyday exposure levels are not harmful. However, the U.S. Environmental Protection Agency (EPA) recognizes “interference with reproduction” as a potential risk from such chemicals. The difficulty lies in pinpointing safe exposure levels, as these chemicals can accumulate over time or interact in the body in complex ways.

Ongoing Research and Alarming Findings 

Research continues to reveal unsettling links between chemicals and reproductive health. For example, perfluoroalkyl and poly-fluoroalkyl substances (PFAS), also known as “forever chemicals,” have been associated with reduced pregnancy rates and increased risks for disorders like polycystic ovary syndrome and endometriosis. Similarly, Bisphenol-A (BPA), used in food can linings and other products, has been connected to fertility problems in both sexes, prompting Europe to propose drastically reducing its acceptable daily intake.

Broader Implications and Future Directions 

Adding to the evidence, public health researcher Shanna Swan found that phthalates, common in scented products, are linked to reduced sperm count and other reproductive issues. Swan’s research indicates a significant decline in human sperm counts over recent decades, mirroring fertility issues observed in animals exposed to the same environments.

This ongoing research underscores the complex web of factors contributing to the global decline in fertility rates. While lifestyle choices and societal changes play a role, the potential impact of environmental chemicals is increasingly hard to ignore. As scientists like Swan and others continue to explore these links, the dialogue around chemical safety and reproductive health is likely to intensify, pushing for more stringent regulations and greater public awareness.

Reference Link – https://www.msn.com/en-us/health/other/as-fertility-rates-fall-some-scientists-say-everyday-chemicals-are-a-factor/ar-AA1vQUof

the festive season while keeping your symptoms under control.

Maintain a Balanced Diet

Navigating holiday eating is crucial for those with PCOS. High-sugar foods and irregular eating can spike insulin levels, aggravating hormonal imbalances. Try to balance indulgent meals with healthier choices. Opt for snacks like vegetable crudités with hummus before heading out to gatherings, and start your day with a protein-rich breakfast like an omelette or Greek yoghurt to stabilize your blood sugar levels.

Incorporate Gentle Exercise

Physical activity can be particularly beneficial for managing PCOS symptoms, enhancing insulin sensitivity, and boosting mood. While the holiday season may disrupt your regular workout routine, integrating physical activity can be as simple as a brisk morning walk or joining a festive-themed fun run. These activities not only help maintain your fitness but also offer a chance to enjoy the holiday spirit in a healthy way.

Plan Alcohol Intake Carefully

Alcohol and PCOS are not the best of friends, as alcohol can lead to sugar spikes and hormonal disturbances. Plan your drinking by setting designated alcohol-free days. When you do choose to drink, pair each alcoholic beverage with a glass of water and avoid drinking on an empty stomach to help manage your insulin levels.

Prioritize Rest and Recovery

Quality sleep is a cornerstone of managing PCOS. The holiday excitement can disrupt sleep patterns, so make it a priority to maintain a regular sleep schedule. Create a calming bedtime routine, limit screen time before bed, and consider using earplugs or a white noise machine if staying in a bustling household.

Stay on Top of Supplements

Supplements like myo-inositol can be vital for managing PCOS. If you’re travelling or out of your regular routine, set reminders to take your supplements consistently. Pairing myo-inositol with alpha-lactalbumin can enhance absorption, making it more effective.

Manage Stress Effectively

The holiday season can heighten stress levels, which in turn can exacerbate PCOS symptoms. Be proactive in managing stress by setting realistic expectations for what you can handle in terms of gatherings and commitments. Allocate time for relaxation and activities that bring you joy, such as reading, meditating, or crafting.

Create Joyful Experiences

Despite the challenges, Christmas is a time to enjoy and make memories. Engage in activities that make you happy and evoke nostalgia, like singing carols or decorating your home. Practising gratitude by reflecting on what you are thankful for can also enhance your mental well-being.

Remember, You’re Not Alone

Remember, you’re not alone in navigating the holidays with PCOS. Many women share similar experiences and connecting with a support group or community can offer additional tips and encouragement.

By planning ahead and making thoughtful choices, you can enjoy the festive season without letting PCOS dictate your holiday experience. Here’s to a joyful and healthy Christmas!

Reference link – https://www.fertilityfamily.co.uk/blog/top-tips-for-managing-christmas-with-pcos/